CN117460428A - Gos预调理的罗伊氏乳杆菌和最终制剂中的gos - Google Patents

Gos预调理的罗伊氏乳杆菌和最终制剂中的gos Download PDF

Info

Publication number
CN117460428A
CN117460428A CN202280021023.3A CN202280021023A CN117460428A CN 117460428 A CN117460428 A CN 117460428A CN 202280021023 A CN202280021023 A CN 202280021023A CN 117460428 A CN117460428 A CN 117460428A
Authority
CN
China
Prior art keywords
lactobacillus reuteri
probiotic
gos
dsm
strain
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN202280021023.3A
Other languages
English (en)
Chinese (zh)
Inventor
S·鲁斯
M·N·霍尔卡雅达
N·邦尼特
M·萨巴缇尔
B·布尔基
G·E·M·普鲁特
F·德布勒因
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Biogaia AB
Original Assignee
Biogaia AB
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Biogaia AB filed Critical Biogaia AB
Publication of CN117460428A publication Critical patent/CN117460428A/zh
Pending legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A61K35/741—Probiotics
    • A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
    • A61K35/747—Lactobacilli, e.g. L. acidophilus or L. brevis
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/135—Bacteria or derivatives thereof, e.g. probiotics
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/125—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives containing carbohydrate syrups; containing sugars; containing sugar alcohols; containing starch hydrolysates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/02—Nutrients, e.g. vitamins, minerals
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00—Microorganisms; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/20—Bacteria; Culture media therefor
    • C12N1/205—Bacterial isolates
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2400/00—Lactic or propionic acid bacteria
    • A23V2400/11—Lactobacillus
    • A23V2400/113—Acidophilus
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12R—INDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS
    • C12R2001/00—Microorganisms ; Processes using microorganisms
    • C12R2001/01—Bacteria or Actinomycetales ; using bacteria or Actinomycetales
    • C12R2001/225—Lactobacillus

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Mycology (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Nutrition Science (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Molecular Biology (AREA)
  • Polymers & Plastics (AREA)
  • Food Science & Technology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Microbiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Wood Science & Technology (AREA)
  • Biochemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Zoology (AREA)
  • Epidemiology (AREA)
  • Biotechnology (AREA)
  • Hematology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Biomedical Technology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Obesity (AREA)
  • Diabetes (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • General Engineering & Computer Science (AREA)
  • Virology (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicinal Preparation (AREA)
CN202280021023.3A 2021-03-12 2022-03-11 Gos预调理的罗伊氏乳杆菌和最终制剂中的gos Pending CN117460428A (zh)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP21162450.7A EP4056052A1 (en) 2021-03-12 2021-03-12 Gos pre-conditioning l. reuteri and gos in final formulation
EP21162450.7 2021-03-12
PCT/SE2022/050245 WO2022191767A1 (en) 2021-03-12 2022-03-11 Gos pre-conditioning l. reuteri and gos in final formulation

Publications (1)

Publication Number Publication Date
CN117460428A true CN117460428A (zh) 2024-01-26

Family

ID=74873671

Family Applications (1)

Application Number Title Priority Date Filing Date
CN202280021023.3A Pending CN117460428A (zh) 2021-03-12 2022-03-11 Gos预调理的罗伊氏乳杆菌和最终制剂中的gos

Country Status (7)

Country Link
US (1) US20230405062A1 (https=)
EP (2) EP4056052A1 (https=)
JP (1) JP2024517546A (https=)
CN (1) CN117460428A (https=)
CA (1) CA3205769A1 (https=)
MX (1) MX2023009930A (https=)
WO (1) WO2022191767A1 (https=)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN116806965A (zh) * 2023-03-10 2023-09-29 内蒙古大学 用于补钙成骨的益生菌骨粉发酵液及其制备方法、用途
CN116814503B (zh) * 2023-07-27 2024-01-30 山东奈思健康科技有限责任公司 一种促补钙护骨的后生元制品及其制备方法和应用
WO2025078557A1 (en) 2023-10-11 2025-04-17 Société des Produits Nestlé S.A. Compositions comprising a probiotic strain for improving muscle strength
CN118726137B (zh) * 2024-06-06 2025-03-25 科为生物(镇江)有限公司 一株可拮抗幽门螺杆菌和修复黏膜屏障损伤的罗伊氏粘液乳杆菌MeetU及其应用
CN120192865A (zh) * 2024-11-07 2025-06-24 河北农业大学 一种罗伊氏粘液乳杆菌mry6及其应用

Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2012115588A1 (en) * 2011-02-23 2012-08-30 Biogaia Ab Indirect substrates for microorganisms metabolizing 1,2-propanediol
CN104244736A (zh) * 2011-12-30 2014-12-24 生命大地女神有限公司 用于肠神经系统发育的罗伊氏乳杆菌dsm17938
US20160263144A1 (en) * 2013-11-05 2016-09-15 Optibiotix Limited Composition & methods of screening
CN111372477A (zh) * 2017-08-04 2020-07-03 雀巢产品有限公司 在含有gos的培养基中预调理的益生菌及其用途
WO2020163398A1 (en) * 2019-02-05 2020-08-13 Elanco Us Inc. Probiotic compositions comprising lactobacillus reuteri strains and methods of use

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2688538T3 (es) 2010-12-23 2018-11-05 Dupont Nutrition Biosciences Aps Composiciones crioprotectoras y uso de las mismas
US20120263696A1 (en) * 2011-04-14 2012-10-18 Stefan Roos Indirect Substrates for Microorganisms Metabolizing 1,2-Propanediol
EP3016511B1 (en) 2013-07-02 2019-10-09 Austrianova Singapore Pte Ltd. A method of freeze-drying encapsulated cells, compositions suitable for freezing of encapsulated cells and use of such compositions
WO2017001590A1 (en) 2015-06-30 2017-01-05 Nestec S.A. Composition suitable for protecting microorganisms

Patent Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2012115588A1 (en) * 2011-02-23 2012-08-30 Biogaia Ab Indirect substrates for microorganisms metabolizing 1,2-propanediol
CN104244736A (zh) * 2011-12-30 2014-12-24 生命大地女神有限公司 用于肠神经系统发育的罗伊氏乳杆菌dsm17938
US20160263144A1 (en) * 2013-11-05 2016-09-15 Optibiotix Limited Composition & methods of screening
CN111372477A (zh) * 2017-08-04 2020-07-03 雀巢产品有限公司 在含有gos的培养基中预调理的益生菌及其用途
WO2020163398A1 (en) * 2019-02-05 2020-08-13 Elanco Us Inc. Probiotic compositions comprising lactobacillus reuteri strains and methods of use

Non-Patent Citations (3)

* Cited by examiner, † Cited by third party
Title
MONCHAYA RATTANAPRASERT AT AL.: "Genes Involved in Galactooligosaccharide Metabolism in Lactobacillus reuteri and Their Ecological Role in the Gastrointestinal Tract", APPLIED AND ENVIRONMENTAL MICROBIOLOGY, 30 October 2019 (2019-10-30), pages 1 - 15 *
MONCHAYA RATTANAPRASERT ET AL.: "Quantitative evaluation of synbiotic strategies to improve persistence and metabolic activity of Lactobacillus reuteri DSM 17938 in the human gastrointestinal tract", JOURNAL OF FUNCTIONAL FOODS, 17 June 2014 (2014-06-17), pages 85 - 94 *
于焕: "益生菌发酵工艺、冻干保护剂优化与活性研究", 中国优秀硕士学位论文全文数据库, 15 March 2018 (2018-03-15), pages 018 - 56 *

Also Published As

Publication number Publication date
EP4152963A1 (en) 2023-03-29
CA3205769A1 (en) 2022-09-15
WO2022191767A1 (en) 2022-09-15
MX2023009930A (es) 2023-09-06
US20230405062A1 (en) 2023-12-21
JP2024517546A (ja) 2024-04-23
EP4056052A1 (en) 2022-09-14

Similar Documents

Publication Publication Date Title
US20230405062A1 (en) Gos pre-conditioning l. reuteri and gos in final formulation
Soccol et al. The potential of probiotics: a review.
RU2543815C2 (ru) Питательные композиции, содержащие лактоферрин и пробиотики, и наборы из их частей
US20100166721A1 (en) Probotic compositions and uses thereof
Maftei Probiotic, Prebiotic and Synbiotic
US20110165127A1 (en) Dairy-derived probiotic compositions and uses thereof
US20080102061A1 (en) Use hydrolyzed medium containing microorganisms medicinally
JP5864676B2 (ja) 貧血の予防又は治療用組成物
Manigandan et al. Probiotics, prebiotics and synbiotics-a review
TW201002216A (en) Probiotics to improve gut microbiota
JP7410336B2 (ja) ラクトバチルス・ガセリｂｎｒ１７を含む更年期疾患治療用組成物
US20230227771A1 (en) Pre-conditioning of l.reuteri
CN108669563A (zh) 一种组合物、其应用和增强免疫力、改善过敏的产品
CN107647410A (zh) 一种复合配比的益生菌粉及其制备方法
US20240156886A1 (en) Gos pre-conditioning lactobacillus strains and gos in final formulation
US20220400729A1 (en) Synergistic combination of butyric-acid-producing prebiotics and probiotics
CN119552766B (zh) 一种嗜黏蛋白阿克曼氏菌株及其应用
US12121550B2 (en) Lactic acid bacterium, blood iron increasing agent, and anemia improving agent
WO2025099321A1 (en) Compositions comprising human milk oligosaccharides and inactivated cells of a microorganism
Mocanu et al. Milk and Dairy Products: Vectors to Create Probiotic Products
SHRIRANGRAO RAHURI-413722, DIST. AHMEDNAGAR, MAHARASHTRA, INDIA
Soccol et al. Mogućnosti primjene probiotika
INGALE MS. SONALI GAWADE AND MS. VAISHNAVI INGALE DEPARTMENT OF MICROBIOLOGY VIVEKANAND COLLEGE, KOLHAPUR
BG2847U1 (bg) Ацидофилно мляко

Legal Events

Date Code Title Description
PB01 Publication
PB01 Publication
SE01 Entry into force of request for substantive examination
SE01 Entry into force of request for substantive examination
CB02 Change of applicant information

Country or region after: Sweden

Address after: Stockholm, SWE

Applicant after: Baiogaya Co.,Ltd.

Address before: Stockholm, SWE

Applicant before: BIOGAIA AB

Country or region before: Sweden

CB02 Change of applicant information